Differential cytokine gene expression according to outcome in a hamster model of leptospirosis

PLoS Neglected Tropical Diseases

Volumn 4, Issue 1, 2010, Pages

  Vernel Pauillac, Frédé Rique ^a   Goarant, Cyrille ^a  

^a Institut Pasteur de Nouvelle Caledonie Noumea   (New Caledonia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; EFFECTOR CELL; GENE EXPRESSION REGULATION; HAMSTER; IMMUNE SYSTEM; LD 50; LEPTOSPIROSIS; MEDIATOR; NONHUMAN; NUCLEOTIDE SEQUENCE; PROGNOSIS; SERUM; SURVIVOR; SYMPTOM; ANIMAL; DISEASE MODEL; GENETICS; IMMUNOLOGY; MICROBIOLOGY; POLYMERASE CHAIN REACTION; SYRIAN HAMSTER;

ANIMALS; CRICETINAE; CYCLOOXYGENASE 2; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; INTERLEUKIN-10; INTERLEUKIN-1ALPHA; LEPTOSPIROSIS; MESOCRICETUS; POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 76249085001     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000582     Document Type: Article

References (60)

1. Levett PN (2001) Leptospirosis. Clin Microbiol Rev 14: 296-326.
2. Goarant C, Laumond-Barny S, Perez J, Vernel-Pauillac F, Chanteau S, et al. (2009) Outbreak of leptospirosis in New Caledonia: diagnosis issues and burden of disease. Trop Med Int Health 14: 926-929.
3. Gaynor K, Katz AR, Park SY, Nakata M, Clark TA, et al. (2007) Leptospirosis on Oahu: an outbreak associated with flooding of a university campus. Am J Trop Med Hyg 76: 882-885.
4. Park SY, Effler PV, Nakata M, Sasaki D, Katz AR, et al. (2006) Brief report: Leptospirosis after flooding of a university campus - Hawaii, 2004. MMWR Morb Mortal Wkly Rep 55: 125-127.
5. Sejvar J, Bancroft E, Winthrop K, Bettinger J, Bajani M, et al. (2003) Leptospirosis in "Eco-Challenge" athletes, Malaysian Borneo, 2000. Emerging Infectious Diseases 9: 702-707.
6. Monahan AM, Miller IS, Nally JE (2009) Leptospirosis: risks during recreational activities. J Appl Microbiol 107: 707-716.
7. Morgan J, Bornstein SL, Karpati AM, Bruce M, Bolin CA, et al. (2002) Outbreak of leptospirosis among triathlon participants and community residents in Springfield, Illinois, 1998. Clin Infect Dis 34: 1593-1599.
8. Desai S, van Treeck U, Lierz M, Espelage W, Zota L, et al. (2009) Resurgence of Field Fever in a Temperate Country: An Epidemic of Leptospirosis among Seasonal Strawberry Harvesters in Germany in 2007. Clin Infect Dis 48: 691-697.
9. Ellis T, Imrie A, Katz AR, Effler PV (2008) Underrecognition of leptospirosis during a dengue fever outbreak in Hawaii, 2001-2002. Vector Borne Zoonotic Dis 8: 541-547.
10. Tajiki MH, Salomão R (1996) Association of plasma levels of Tumour Necrosis Factor α with severity of disease and mortality among patients with leptospirosis. Clinical Infectious Disease 23: 1177-1178.
11. Wagenaar JF, Gasem MH, Goris MG, Leeflang M, Hartskeerl RA, et al. (2009) Soluble ST2 Levels Are Associated with Bleeding in Patients with Severe Leptospirosis. PLoS Negl Trop Dis 3: e453. doi:10.1371/journal.pntd.0000453.
12. Yang CW, Hung CC, Wu MS, Tian YC, Chang CT, et al. (2006) Toll-like receptor 2 mediates early inflammation by leptospiral outer membrane proteins in proximal tubule cells. Kidney Int 69: 815-822.
13. Sfeir T, Saha DC, Astiz M, Rackow EC (2001) Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock. Crit Care Med 29: 129-133.
14. Mege JL, Meghari S, Honstettre A, Capo C, Raoult D (2006) The two faces of interleukin 10 in human infectious diseases. Lancet Infect Dis 6: 557-569.
15. Arnalich F, Garcia-Palomero E, Lopez J, Jimenez M, Madero R, et al. (2000) Predictive value of nuclear factor kappaB activity and plasma cytokine levels in patients with sepsis. Infect Immun 68: 1942-1945.
16. Bozza FA, Salluh JI, Japiassu AM, Soares M, Assis EF, et al. (2007) Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care 11: R49.
17. van Dissel JT, van Langevelde P, Westendorp RG, Kwappenberg K, Frolich M (1998) Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet 351: 950-953.
18. Barber RC, Chang LY, Arnoldo BD, Purdue GF, Hunt JL, et al. (2006) Innate immunity SNPs are associated with risk for severe sepsis after burn injury. Clin Med Res 4: 250-255.
19. Booy R, Nadel S, Hibberd M, Levin M, Newport MJ (1997) Genetic influence on cytokine production in meningococcal disease. Lancet 349: 1176.
20. Cavaillon JM, Adib-Conquy M, Fitting C, Adrie C, Payen D (2003) Cytokine cascade in sepsis. Scand J Infect Dis 35: 535-544.
21. Cohen J (2002) The immunopathogenesis of sepsis. Nature 420: 885-891.
22. Shtrichman R, Samuel CE (2001) The role of gamma interferon in antimicrobial immunity. Curr Opin Microbiol 4: 251-259.
23. Chierakul W, de Fost M, Suputtamongkol Y, Limpaiboon R, Dondorp A, et al. (2004) Differential expression of interferon-γ and interferon-γ- inducing cytokines in Thai patients with scrub typhus or leptospirosis. Clin Immunol 113: 140-144.
24. Kang YJ, Wingerd BA, Arakawa T, Smith WL (2006) Cyclooxygenase-2 gene transcription in a macrophage model of inflammation. J Immunol 177: 8111-8122.
25. Hauck W, Samlalsingh-Parker J, Glibetic M, Ricard G, Beaudoin MC, et al. (1999) Deregulation of cyclooxygenase and nitric oxide synthase gene expression in the inflammatory cascade triggered by experimental group B streptococcal meningitis in the newborn brain and cerebral microvessels. Semin Perinatol 23: 250-260.
26. Maciel EA, Athanazio DA, Reis EA, Cunha FQ, Queiroz A, et al. (2006) High serum nitric oxide levels in patients with severe leptospirosis. Acta Trop 100: 256-260.
27. Al-Ashy R, Chakroun I, El-Sabban ME, Homaidan FR (2006) The role of NF-kappaB in mediating the anti-inflammatory effects of IL-10 in intestinal epithelial cells. Cytokine 36: 1-8.
28. Berg DT, Gupta A, Richardson MA, O'Brien LA, Calnek D, et al. (2007) Negative regulation of inducible nitric-oxide synthase expression mediated through transforming growth factor-beta-dependent modulation of transcription factor TCF11. J Biol Chem 282: 36837-36844.
29. Haake DA (2006) Hamster model of leptospirosis. Curr Protoc Microbiol Chapter 12: Unit 12E 12.
30. Silva EF, Santos CS, Athanazio DA, Seyffert N, Seixas FK, et al. (2008) Characterization of virulence of Leptospira isolates in a hamster model. Vaccine 26: 3892-3896.
31. Truccolo J, Charavay F, Merien F, Perolat P (2002) Quantitative PCR Assay To Evaluate Ampicillin, Ofloxacin, and Doxycycline for Treatment of Experimental Leptospirosis. Antimicrob Agents Chemother 46: 848-853.
32. Praditpornsilpa K, Sangjun N, Kittikowit W, Phulsuksombati D, Avihingsanon Y, et al. (2006) Alleviation of renal and pulmonary injury by immunomodulation in leptospirosis: hamster model. J Med Assoc Thai 89 (Suppl 2): S178-187.
33. Ristow P, Bourhy P, McBride FW, Figueira CP, Huerre M, et al. (2007) The OmpA-Like Protein Loa22 Is Essential for Leptospiral Virulence. PLoS Pathog 3: e97.
34. Silva EF, Medeiros MA, McBride AJ, Matsunaga J, Esteves GS, et al. (2007) The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis. Vaccine 25: 6277-6286.
35. Srikram A, Wongratanacheewin S, Puapairoj A, Wuthiekanun V, Sermswan RW (2008) Analyses of vaccination protocols for Leptospira interrogans serovar autumnalis in hamsters. Am J Trop Med Hyg 79: 779-786.
36. van den Ingh TS, Hartman EG (1986) Pathology of acute Leptospira interrogans serotype icterohaemorrhagiae infection in the Syrian hamster. Vet Microbiol 12: 367-376.
37. Yan W, Faisal SM, McDonough SP, Divers TJ, Barr SC, et al. (2008) Immunogenicity and protective efficacy of recombinant Leptospira immunoglobulin-like protein B (rLigB) in a hamster challenge model. Microbes Infect 11: 230-237.
38. Vernel-Pauillac F, Merien F (2006) Proinflammatory and Immunomodulatory Cytokine mRNA time course profiles in hamsters infected with a virulent variant of Leptospira interrogans. Infection and Immunity 74: 4172-4179.
39. Truccolo J, Serais O, Merien F, Perolat P (2001) Following the course of human leptospirosis: evidence of a critical threshold for the vital prognosis using a quantitative PCR assay. FEMS Microbiology Letters 204: 317-321.
40. Ellinghausen HC, Jr., McCullough WG (1965) Nutrition of Leptospira Pomona and Growth of 13 Other Serotypes: Fractionation of Oleic Albumin Complex and a Medium of Bovine Albumin and Polysorbate 80. Am J Vet Res 26: 45-51.
41. Overbergh L, Giulietti A, Valckx D, Decallonne R, Bouillon R, et al. (2003) The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J Biomol Tech 14: 33-43.
42. Merien F, Amouriaux P, Perolat P, Baranton G, Saint Girons I (1992) Polymerase chain reaction for detection of Leptospira spp. in clinical samples. J Clin Microbiol 30: 2219-2224.
43. Larkin P, Folmar LC, Hemmer MJ, Poston AJ, Denslow ND (2003) Expression profiling of estrogenic compounds using a sheepshead minnow cDNA macroarray. EHP Toxicogenomics 111: 29-36.
44. Wang W, Yang L, Suwa T, Casson PR, Hornsby PJ (2001) Differentially expressed genes in zona reticularis cells of the human adrenal cortex. Mol Cell Endocrinol 173: 127-134.
45. Merien F, Baranton G, Perolat P (1997) Invasion of Vero cells and induction of apoptosis in macrophages by pathogenic Leptospira Interrogans are correlated with virulence. Infect Immun 65: 729-738.
46. Merien F, Truccolo J, Rougier Y, Baranton G, Perolat P (1998) In vivo apoptosis of hepatocytes in guinea pigs infected with Leptospira interrogans serovar icterohaemorrhagiae. FEMS Microbiol Lett 169: 95-102.
47. Lowanitchapat A, Payungporn S, Seeremaspun A, Ekpo P, Phulsuksombati D, et al. (2009) Expression of TNF-alpha, TGF-beta, IP-10 and IL-10 mRNA in kidneys of hamsters infected with pathogenic Leptospira. Comp Immunol Microbiol Infect Dis. E-pub ahead of print. doi:10.1016/j.cimid.2009.05.001.
48. Deutscher MP (2003) Degradation of stable RNA in bacteria. J Biol Chem 278: 45041-45044.
49. Poulsen LK, Ballard G, Stahl DA (1993) Use of rRNA fluorescence in situ hybridization for measuring the activity of single cells in young and established biofilms. Appl Environ Microbiol 59: 1354-1360.
50. Cavaillon JM, Munoz C, Fitting C, Misset B, Carlet J (1992) Circulating cytokines: the tip of the iceberg? Circ Shock 38: 145-152.
51. Philippart F, Cavaillon JM (2007) Sepsis mediators. Curr Infect Dis Rep 9: 358-365.
52. Stylianou E, Saklatvala J (1998) Interleukin-1. Int J Biochem Cell Biol 30: 1075-1079.
53. Dinarello CA (1994) The interleukin-1 family: 10 years of discovery. Faseb J 8: 1314-1325.
54. Gogos CA, Drosou E, Bassaris HP, Skoutelis A (2000) Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 181: 176-180.
55. Garnacho-Montero J, Aldabo-Pallas T, Garnacho-Montero C, Cayuela A, Jimenez R, et al. (2006) Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis. Crit Care 10: R111.
56. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A (1991) IL-10 inhibits cytokine production by activated macrophages. J Immunol 147: 3815-3822.
57. Tajiki MH, Nakama ASY, Salomão R (1997) The Ratio Of Plasma Levels Of Il-10/Tnf-Alpha And Its Relationship To Disease Severity And Survival In Patients With Leptospirosis. Braz J Infect Dis 1: 138-141.
58. Abe R, Hirasawa H, Oda S, Sadahiro T, Nakamura M, et al. (2008) Upregulation of interleukin-10 mRNA expression in peripheral leukocytes predicts poor outcome and diminished human leukocyte antigen-DR expression on monocytes in septic patients. J Surg Res 147: 1-8.
59. Yang H, Wang H, Czura CJ, Tracey KJ (2005) The cytokine activity of HMGB1. J Leukoc Biol 78: 1-8.
60. Ulloa L, Tracey KJ (2005) The "cytokine profile": a code for sepsis. Trends Mol Med 11: 56-63.